{"id":"https://openalex.org/W2581748142","doi":null,"title":"Gene expression analysis of Manumycin, a natural farnesyltransferase (FTase) inhibitor, in drug-resistant IL-6-producing myeloma cells.","display_name":"Gene expression analysis of Manumycin, a natural farnesyltransferase (FTase) inhibitor, in drug-resistant IL-6-producing myeloma cells.","publication_year":2005,"publication_date":"2005-05-01","ids":{"openalex":"https://openalex.org/W2581748142","mag":"2581748142"},"language":"en","primary_location":{"id":"mag:2581748142","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/65/9_Supplement/14.3","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069986334","display_name":"Sergio Marchini","orcid":"https://orcid.org/0000-0003-1783-7651","observed_orcids":["https://orcid.org/0000-0003-1783-7651"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sergio Marchini","raw_affiliation_strings":["Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy"],"raw_orcid":"https://orcid.org/0000-0003-1783-7651","affiliations":[{"raw_affiliation_string":"Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048173478","display_name":"Eleonora Marrazzo","orcid":"https://orcid.org/0000-0003-4832-3485","observed_orcids":["https://orcid.org/0000-0003-4832-3485"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eleonora Marrazzo","raw_affiliation_strings":["Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy"],"raw_orcid":"https://orcid.org/0000-0003-4832-3485","affiliations":[{"raw_affiliation_string":"Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Riccardo Bonomi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Riccardo Bonomi","raw_affiliation_strings":["Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053859779","display_name":"Luigi Mastromauro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luigi Mastromauro","raw_affiliation_strings":["Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059590463","display_name":"Anna Maria Frassanito","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Maria Frassanito","raw_affiliation_strings":["Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035793612","display_name":"Pietro Mariani","orcid":"https://orcid.org/0009-0008-2892-2433","observed_orcids":["https://orcid.org/0009-0008-2892-2433"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pietro Mariani","raw_affiliation_strings":["Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004120841","display_name":"T. Fusaro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Fusaro","raw_affiliation_strings":["Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091714925","display_name":"Massimo Broggini","orcid":"https://orcid.org/0000-0002-8138-9358","observed_orcids":["https://orcid.org/0000-0002-8138-9358"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Massimo Broggini","raw_affiliation_strings":["Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy"],"raw_orcid":"https://orcid.org/0000-0002-8138-9358","affiliations":[{"raw_affiliation_string":"Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055332109","display_name":"Franco Dammacco","orcid":"https://orcid.org/0000-0003-2149-5471","observed_orcids":["https://orcid.org/0000-0003-2149-5471"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Franco Dammacco","raw_affiliation_strings":["Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy"],"raw_orcid":"https://orcid.org/0000-0003-2149-5471","affiliations":[{"raw_affiliation_string":"Institute Mario Negri, Milan, Italy and DIMO - Department of Internal Medicine and Oncology, Policlinico Bari, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"65","issue":null,"first_page":"14","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/manumycin","display_name":"manumycin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7200000286102295},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8100000023841858},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.8690000176429749},{"id":"https://openalex.org/keywords/caspase-8","display_name":"caspase-8","score":1.0},{"id":"https://openalex.org/keywords/flip","display_name":"c-FLIP","score":0.796999990940094},{"id":"https://openalex.org/keywords/nf-kb","display_name":"NF-kB","score":0.9340000152587891},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.8569999933242798},{"id":"https://openalex.org/keywords/fas-mediated-apoptosis","display_name":"Fas-mediated apoptosis","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2778396349","wikidata":"https://www.wikidata.org/wiki/Q410994","display_name":"Farnesyltransferase","level":4,"score":0.8035570383071899},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6691811680793762},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6683784127235413},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5371819734573364},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5154646039009094},{"id":"https://openalex.org/C2777827897","wikidata":"https://www.wikidata.org/wiki/Q5436005","display_name":"Farnesyltransferase inhibitor","level":5,"score":0.49845170974731445},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.47008585929870605},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4502028822898865},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4152084290981293},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4136436879634857},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2305985987186432},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1293574869632721},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.10206270217895508},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2581748142","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/65/9_Supplement/14.3","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1965072784","https://openalex.org/W2039468151","https://openalex.org/W2260428309","https://openalex.org/W7098222088","https://openalex.org/W2153052781","https://openalex.org/W2021120405","https://openalex.org/W2011944110","https://openalex.org/W2466952093","https://openalex.org/W2086394230","https://openalex.org/W1921369660"],"abstract_inverted_index":{"60":[0],"Background:":[2],"Multiple":[3],"myeloma":[4,47,68,81,153],"(MM)":[5],"is":[6,13],"a":[7,30,61,232,253],"severe":[8],"plasma":[9],"cell":[10,100],"malignancy":[11],"which":[12],"frequently":[14],"characterised,":[15],"at":[16,206,248],"molecular":[17,208],"level,":[18,209],"by":[19,104,121,129,141,172,183,220],"constitutive":[20],"Ras":[21,125,164],"activation.":[22],"FTase":[23,63],"has":[24],"emerged":[25],"in":[26,133,215,231],"the":[27,34,57,162,207,210],"past":[28],"as":[29],"potential":[31],"target":[32],"for":[33,91],"development":[35],"of":[36,59,79,152,161,176,194,212,227,234],"new":[37],"anti-cancer":[38],"agents.":[39],"Based":[40],"on":[41,65],"our":[42],"previous":[43],"demonstration":[44],"that":[45,169,226,247],"IL-6-producing":[46],"cells":[48,230],"are":[49],"refractory":[50],"to":[51,93,159,203,225],"Fas-drug-induced":[52],"apoptosis,":[53],"we":[54],"have":[55],"analyzed":[56],"effect":[58,156],"manumycin,":[60,213],"natural":[62],"inhibitor,":[64],"these":[66],"IL-6-positive":[67],"cells.":[69,154],"Methods:":[70],"Myeloma":[71],"cells,":[72],"freshly":[73],"purified":[74],"from":[75],"bone":[76],"marrow":[77],"aspirates":[78],"7":[80],"patients":[82],"using":[83],"CD138-microbeads,":[84],"were":[85,119,139,223],"incubated":[86],"with":[87,192,252],"manumycin":[88,137,173,221],"(10":[89],"\u03bcM)":[90],"6":[92],"24":[94],"hours.":[95],"Drug":[96],"activity":[97],"and":[98,107,114,149,178,180,198],"tumor":[99],"apoptosis":[101,151,170,189],"was":[102,127,157,181,190],"evaluated":[103,120,128,140],"MTT":[105],"assay":[106],"BrdU/PI":[108],"staining,":[109],"respectively.":[110],"Caspase":[111],"activation,":[112],"Flip":[113],"Apo":[115],"2.7":[116],"Ag":[117],"expression":[118,135,217],"flow":[122],"cytometry.":[123],"Post-translational":[124],"processing":[126],"Western":[130],"blotting.":[131],"Changes":[132],"gene":[134,216],"after":[136],"treatment":[138,222],"microarray":[142],"technique":[143],".":[144],"Results:":[145],"Manumycin":[146],"prevented":[147,182],"proliferation":[148],"induced":[150,171,219],"The":[155],"related":[158],"inhibition":[160,193],"post-translational":[163],"processing.":[165],"Further":[166],"analysis":[167],"showed":[168],"involved":[174],"activation":[175],"caspase-3":[177],"-8":[179],"specific":[184],"caspase":[185],"inhibitors.":[186],"Furthermore,":[187],"manumycin-induced":[188],"associated":[191],"constitutively":[195],"active":[196],"NF-kB":[197],"FLIP":[199],"expression.":[200],"In":[201],"order":[202],"better":[204],"characterise,":[205],"effects":[211],"changes":[214],"profile":[218],"compared":[224],"control":[228],"untreated":[229],"panel":[233],"7600":[235],"genes":[236,251],"(Atlass":[237],"Glass":[238],"Array,":[239],"Beckton":[240],"Dickinson,":[241],"Milan":[242],"Italy).":[243],"Data":[244],"mining":[245],"revealed":[246],"least":[249],"40":[250],"z":[254],"score":[255],">":[256],"or":[257]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-02-03T00:00:00"}